| Date Filed | Type | Description |
| 02/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2022 |
3
| Rolke James (CEO) has filed a Form 3 on REVELATION BIOSCIENCES, INC. |
| 06/02/2020 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 205 shares
@ $4.01, valued at
$822.1
Granted 205 options to buy
@ $4.72, valued at
$967.6 |
|
| 05/19/2020 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 140 shares
@ $5.86, valued at
$820.4
Granted 140 options to buy
@ $6.89, valued at
$964.6 |
|
| 05/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2020 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 146 shares
@ $5.61, valued at
$819.1
Granted 146 options to buy
@ $6.6, valued at
$963.6 |
|
| 04/02/2020 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 229 shares
@ $3.57, valued at
$817.5
Granted 229 options to buy
@ $4.2, valued at
$961.8 |
|
| 03/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2020 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 692 shares
@ $6.7, valued at
$4.6k
Granted 692 options to buy
@ $7.88, valued at
$5.5k
|
|
| 01/13/2020 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 30,000 options to buy
@ $5.25, valued at
$157.5k
|
|
| 11/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/05/2019 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 133 shares
@ $5.96, valued at
$792.7
Granted 133 options to buy
@ $7.02, valued at
$933.7 |
|
| 10/17/2019 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 112 shares
@ $7.12, valued at
$797.4
Granted 112 options to buy
@ $8.38, valued at
$938.6 |
|
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2019 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 98 shares
@ $8.13, valued at
$796.7
Granted 98 options to buy
@ $9.57, valued at
$937.9 |
|
| 08/16/2019 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 99 shares
@ $8.02, valued at
$794
Granted 99 options to buy
@ $9.43, valued at
$933.6 |
|
| 08/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2019 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 102 shares
@ $7.85, valued at
$800.7
Granted 102 options to buy
@ $9.24, valued at
$942.5 |
|
| 07/01/2019 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 101 shares
@ $7.86, valued at
$793.9
Granted 101 options to buy
@ $9.25, valued at
$934.3 |
|
| 06/18/2019 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 96 shares
@ $8.25, valued at
$792
Granted 96 options to buy
@ $9.71, valued at
$932.2 |
|
| 06/03/2019 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 174 shares
@ $4.58, valued at
$796.9
Granted 174 options to buy
@ $5.39, valued at
$937.9 |
|
| 05/17/2019 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 143 shares
@ $5.58, valued at
$797.9
Granted 143 options to buy
@ $6.57, valued at
$939.5 |
|
| 05/02/2019 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 116 shares
@ $6.84, valued at
$793.4
Granted 116 options to buy
@ $8.05, valued at
$933.8 |
|
| 04/17/2019 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 131 shares
@ $6.09, valued at
$797.8
Granted 131 options to buy
@ $7.16, valued at
$938 |
|
| 04/02/2019 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 146 shares
@ $5.47, valued at
$798.6
Granted 146 options to buy
@ $6.43, valued at
$938.8 |
|
| 03/19/2019 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 122 shares
@ $6.49, valued at
$791.8
Granted 122 options to buy
@ $7.64, valued at
$932.1 |
|
| 03/04/2019 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 164 shares
@ $4.85, valued at
$795.4
Granted 164 options to buy
@ $5.7, valued at
$934.8 |
|
| 02/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2019 |
4
| Rolke James (Chief Scientific Officer) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 53,000 options to buy
@ $5.99, valued at
$317.5k
|
|
|